A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of Acute
Latest Information Update: 01 Feb 2022
At a glance
- Drugs Remestemcel-L (Primary) ; Ciclosporin; Corticosteroids; Methylprednisolone; Mycophenolate mofetil; Prednisone; Tacrolimus
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.